Amn Healthcare Services Inc (AMN)
NYSE:AMN
Want to see AMN full AI Analyst Report?
Earnings Data
Report Date
Aug 06, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.19Last Year’s EPS
0.3Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed a constructive operational and financial performance with a notable beat to revenue and strong adjusted EBITDA and cash generation, driven in large part by extraordinary execution on multiple labor disruption events and effective deployment of technology and AI. Several underlying businesses showed healthy momentum ex-event (Nurse & Allied ex-disruption, international recovering, search growth), and the balance sheet strengthened (paid down revolver, leverage at 1.6x). Offsetting these positives are material risks and near-term headwinds: a large portion of Q1 results were driven by unpredictable labor disruption and rapid-response revenue that management does not expect to fully recur, ongoing pricing pressure and volume declines in parts of Physician & Leadership and Technology & Workforce Solutions, and short-term cash normalization as client deposits are refunded. Management provided conservative Q2 guidance reflecting these dynamics, while outlining a path to sustained growth aided by technology, operational improvements and anticipated market stabilization into 2027.Company Guidance
Quarterly Revenue Beat and Scale Execution
Consolidated revenue of $1.38 billion in Q1, above guidance and consensus (exceeded guidance by $122 million). Demonstrated ability to rapidly scale operations by supporting five labor disruption events (three large, two indefinite) and deploying thousands of clinicians.
Strong Profitability and Cash Generation
Adjusted EBITDA of $166 million (12.1% of revenue), above the high end of guidance; adjusted EBITDA margin improved +280 bps year-over-year and +480 bps sequentially. Net income of $62 million vs. a net loss of $1 million in the prior year quarter. Operating cash flow of $562 million and capex of $7 million.
Improved Balance Sheet and Leverage
Ended the quarter with $551 million in cash and equivalents, paid down the revolver and reduced leverage to 1.6x (credit-agreement basis). Total debt $750 million. Management expects leverage to remain at or below ~2x for the remainder of the year.
Nurse & Allied Segment Momentum (Excluding Event Revenue)
Nurse & Allied segment revenue was $1.13 billion (includes $722 million labor disruption). Excluding the $722 million of labor disruption revenue, the segment was $405 million, up 8% year-over-year and up 11% sequentially. Travel nurse revenue (ex-disruption) grew ~12% year-over-year; allied revenue up 3% year-over-year.
Gross Margin and Segment Margin Strength
Consolidated gross margin of 26.8%, above guidance. Nurse & Allied gross margin was 25.1%, up 240 bps year-over-year and 350 bps sequentially (benefitted from labor disruption and rapid response mix).
Technology Adoption and AI-Enabled Deployment
WorkWise and AI investments drove tangible outcomes: AI recruiter deployed more than 10,000 clinicians in Q1. AMN Passport users increased >30% year-over-year and monthly active users increased >50% year-over-year. New AI-driven WorkWise features rolled out to improve hiring speed and candidate matching.
International and Search Recoveries
International staffing returned to year-over-year growth (management cited ~17% quarter-over-quarter growth) and leadership search (physician permanent placement and executive searches) returned to year-over-year revenue growth.
Operational Improvements—DSO and Client Relationships
Reported DSO of 26 days; excluding working capital effects from the large labor disruption event, DSO was 54 days (4 days lower year-over-year, 2 days lower sequentially). Management highlighted strengthened client relationships from crisis support and renewed/expanded contracts with major locums clients.
AMN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AMN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2026 | $22.45 | $28.97 | +29.04% |
Feb 19, 2026 | $17.28 | $19.32 | +11.81% |
Nov 06, 2025 | $18.43 | $17.87 | -3.04% |
Aug 07, 2025 | $16.92 | $17.24 | +1.89% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Amn Healthcare Services Inc (AMN) report earnings?
Amn Healthcare Services Inc (AMN) is schdueled to report earning on Aug 06, 2026, After Close (Confirmed).
What is Amn Healthcare Services Inc (AMN) earnings time?
Amn Healthcare Services Inc (AMN) earnings time is at Aug 06, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AMN EPS forecast?
AMN EPS forecast for the fiscal quarter 2026 (Q2) is 0.19.